SAN DIEGO-- (BUSINESS WIRE) -- Minnow Medical, Inc., a developer of innovative products to treat artery disease, today announced that President and Chief Executive Officer Tom Steinke is scheduled to make an investor presentation at the Canaccord Adams 3^rd Annual Cardiovascular Conference on Tuesday, November 10, 2009 at 3:30 p.m. Pacific time. The conference is being held at the Nikko Hotel in San Francisco.

About Minnow Medical, Inc.

Minnow Medical is an innovative cardiovascular medical device company applying its extensive experience in cardiovascular biology, radiofrequency energy and tissue biology to the treatment of peripheral artery disease. The Company’s recently developed Z Cath™ System combines a balloon angioplasty catheter with non-ablative radio frequency energy to shrink atherosclerotic plaque, thereby increasing blood flow. Minnow’s technology received the CE Mark for commercialization in Europe in April 2009. The Company was founded in 2003 and is based in San Diego, California.